What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

What Were Key 340B Developments in 2025, and What’s Ahead for 2026?

What Were Key 340B Developments in 2025, and What’s Ahead for 2026?

Federal and state reform has shaped 340B developments this year. These developments could change how hospitals, health centers, and pharmacies manage drug pricing, eligibility, patient access, and cash flow. Below we share three major changes from 2025 and what we expect to see in 2026. Read More > 

VytlOne

VytlOne News & Announcements

VytlOne offers hospital systems proven solutions for optimizing pharmacy services’ positive impact on the continuum of care; solutions ranging from management of 340B prescription-savings programs, Retail and Specialty Pharmacy operations, to Prescription Benefits program management, patient financial assistance and Readmission Reduction programs.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from What Were Key 340B Developments in 2025, and What’s Ahead for 2026?

Name
Address
Subscribe